Chen J - Search Results

1

Prognostic differences of refractory/relapsed nodal and extranodal diffuse large B-cell lymphoma in the chimeric antigen receptor T cell therapy era.

Song Z, Xu L, Tang G, Gao L, Wang L, Ni X, Chen L, Chen J, Wang T, Feng D, Yu X, Yang J, Wang Y. Song Z, et al. Among authors: chen j, chen l. Clin Chim Acta. 2022 Jul 1;532:72-78. doi: 10.1016/j.cca.2022.05.018. Epub 2022 Jun 2. Clin Chim Acta. 2022. PMID: 35660013

2

Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL).

Liu B, Li B, Zhou P, Yue W, Wang T, Wang J, Hu X, Zhang W, Chen J, Chen L, Gao L, He M, Yang J. Liu B, et al. Among authors: chen j, chen l. Clin Chim Acta. 2018 Jul;482:191-198. doi: 10.1016/j.cca.2018.04.013. Epub 2018 Apr 9. Clin Chim Acta. 2018. PMID: 29649456

3

Chimeric Antigen Receptor-modified Donor Lymphocyte Infusion Improves the Survival of Acute Lymphoblastic Leukemia Patients With Relapsed Diseases After Allogeneic Hematopoietic Stem Cell Transplantation.

Wang T, Gao L, Hu X, Liu B, Chen J, Zhang W, Wang J, Yu X, Feng D, Chang AE, Max W, Tang G, Li Q, Yang J. Wang T, et al. Among authors: chen j. J Immunother. 2019 Apr;42(3):81-88. doi: 10.1097/CJI.0000000000000257. J Immunother. 2019. PMID: 30829725

4

Hematopoietic stem cell transplantation and chimeric antigen receptor T cell for relapsed or refractory diffuse large B-cell lymphoma.

Wang T, Gao L, Wang Y, Zhu W, Xu L, Wang Y, Yue W, Tang G, Chen L, Chen J, Zhang W, Yu X, Feng D, Yang J. Wang T, et al. Among authors: chen j, chen l. Immunotherapy. 2020 Sep;12(13):997-1006. doi: 10.2217/imt-2020-0075. Epub 2020 Aug 5. Immunotherapy. 2020. PMID: 32752910 Free PMC article.

5

Chimeric antigen receptor T-cell therapy combined with autologous stem cell transplantation improved progression-free survival of relapsed or refractory diffuse large B-cell lymphoma patients: A single-center, retrospective, cohort study.

Wang T, Xu L, Gao L, Tang G, Chen L, Chen J, Wang Y, Fu W, Yue W, Ye M, Yu J, Yu X, Feng D, Zhang A, Yang J. Wang T, et al. Among authors: chen j, chen l. Hematol Oncol. 2022 Oct;40(4):637-644. doi: 10.1002/hon.2975. Epub 2022 Feb 22. Hematol Oncol. 2022. PMID: 35141937

6

The risk factors and early predictive model of hematotoxicity after CD19 chimeric antigen receptor T cell therapy.

Wang Y, Song Z, Geng Y, Gao L, Xu L, Tang G, Ni X, Chen L, Chen J, Wang T, Fu W, Feng D, Yu X, Wang L, Yang J. Wang Y, et al. Among authors: chen j, chen l. Front Oncol. 2022 Sep 30;12:987965. doi: 10.3389/fonc.2022.987965. eCollection 2022. Front Oncol. 2022. PMID: 36249041 Free PMC article.

7

Interleukin 10 enhanced CD8+ T cell activity and reduced CD8⁺ T cell apoptosis in patients with diffuse large B cell lymphoma.

Qiu H, Hu X, Gao L, Chen L, Chen J, Yuan J, Huang C, Xu X, Yang J. Qiu H, et al. Among authors: chen j, chen l. Exp Cell Res. 2017 Nov 15;360(2):146-152. doi: 10.1016/j.yexcr.2017.08.036. Epub 2017 Sep 1. Exp Cell Res. 2017. PMID: 28870600

8

MYD88 L265P mutation promoted malignant B cell resistance against T cell-mediated cytotoxicity via upregulating the IL-10/STAT3 cascade.

Qiu H, Gong S, Xu L, Cheng H, Gao L, Chen J, Hu X, Yang J. Qiu H, et al. Among authors: chen j. Int Immunopharmacol. 2018 Nov;64:394-400. doi: 10.1016/j.intimp.2018.09.024. Epub 2018 Sep 22. Int Immunopharmacol. 2018. PMID: 30253331

9

Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II study.

Zhang WP, Wang ZW, Hu XX, Chen J, Yang D, Song XM, Gao L, Ni X, Chen L, Xia XX, Zhou H, Tang GS, Cheng H, Luo YR, Li HM, Yang JM, Wang JM. Zhang WP, et al. Among authors: chen j, chen l. Bone Marrow Transplant. 2019 Jun;54(6):894-902. doi: 10.1038/s41409-018-0356-5. Epub 2018 Oct 19. Bone Marrow Transplant. 2019. PMID: 30337697 Clinical Trial.

10

Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide: A case report.

Yang D, Zhang WP, Yang JM, He MX, Cheng C, Chen J. Yang D, et al. Among authors: chen j. Medicine (Baltimore). 2018 Dec;97(49):e13093. doi: 10.1097/MD.0000000000013093. Medicine (Baltimore). 2018. PMID: 30544372 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138,829 results

Search Page

Filters